Linked Life Data

19298022

Source:http://linkedlifedata.com/resource/pubmed/id/19298022

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12 Suppl 2
pubmed:dateCreated
2009-3-20
pubmed:abstractText
This study reviews the early clinical experience with the Birmingham Hip resurfacing system (Smith & Nephew, Memphis, Tenn) in the United States since its approval by the FDA. A total of 230 patients were followed for a mean of 16 months (range, 6 months). There was a significant improvement in the mean preoperative Oxford hip score at the latest follow-up (44 points [range, 30-58 points] to 17 points [range, 12-28 points]). The most commonly used femoral component was 50 mm, and the mean duration of the procedures was 95 minutes (range, 65-180 min). there were 3 revisions (1.3%). Early results are favorable. As with any device, there is a continuing need for longterm monitoring and large-scale epidemiologic surveillance.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1938-2367
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Early clinical experience with the use of the Birmingham hip resurfacing system.
pubmed:affiliation
Departmetn of Orthopaedics and Sports Medicine, University of South Florida, 3500 East Fletcher Avenue, Suite 511, MDC106, Tampa, FL 33613, USA.
pubmed:publicationType
Journal Article, Clinical Trial